Stay updated on MAPP2 MDMA Therapy Clinical Trial
Sign up to get notified when there's something new on the MAPP2 MDMA Therapy Clinical Trial page.

Latest updates to the MAPP2 MDMA Therapy Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedRevision: v3.4.2 appears on the page, and previous revision notices (v3.4.1) and related funding notices have been updated or removed. These are administrative site updates and do not modify the study content or how users interact with the page.SummaryDifference0.4%

- Check21 days agoChange DetectedAdded a government funding/operating status notice. Updated publications to include the Nat Med 2023 MAPP2 trial citation and revision v3.4.1, and removed the Nat Med 2024 erratum reference.SummaryDifference0.4%

- Check28 days agoChange DetectedThe page now adds a 'Show glossary' option and displays updated metadata labels 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0'. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' have been removed.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision labels updated: v3.3.4 added and v3.3.3 removed.SummaryDifference0.0%

- Check49 days agoChange DetectedThe Publications entry for the Nat Med article was updated to include the 2024 erratum, replacing the 2023 citation.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations section updated to include California, Colorado, Connecticut, Louisiana, Massachusetts, New York, South Carolina, and Wisconsin, with the page revision updated from v3.3.2 to v3.3.3.SummaryDifference0.9%

Stay in the know with updates to MAPP2 MDMA Therapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MAPP2 MDMA Therapy Clinical Trial page.